US 11654147
ALK2 inhibitors and methods for inhibiting BMP signaling
granted A61KA61K31/519A61K31/5377
Quick answer
US patent 11654147 (ALK2 inhibitors and methods for inhibiting BMP signaling) held by The United States of America as Represented by the Secretary, Dept. of Health and Human Services expires Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary, Dept. of Health and Human Services
- Grant date
- Tue May 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/519, A61K31/5377, A61K31/551, A61K31/675